PDx News & Insights
Post categorized under: PDx News & Insights
PathogenDx delivers viral testing solutions for a new era dominated by the global pandemic, and is at the forefront of cannabis, and food testing. We are answering the challenge of individuals, communities and the moment itself, while monitoring the global conversation around pathogen testing to offer even more powerful solutions. Catch up on the latest news driving the future of safe.
- PathogenDx, Axiology Labs Ink Deal to Distribute Detectx-Cv Assay Across Africa and Thailand
Axiology Labs will distribute PathogenDx’s Detectx-Cv Clade Variant equipment and testing kits to its lab network across Africa and Thailand. Axiology Labs will install, train, support, and service its locations across these markets in identifying SARS-CoV-2 variants.
- AOAC Approves PathogenDx QuantX Assay
On August 11, the company received an AOAC Performance Tested Methods Certificate for the QuantX
yeast and mold test. QuantX was designed specifically with cannabis and hemp testing in mind, and to expedite and simplify microbiological testing. QuantX quantifies the total amount of yeast and mold in a sample while also measuring against safety standards. - Our leadership in COVID-19 testing aimed at detecting variants
The flexibility of the PathogenDx Microarray has led to ultra-rapid, low-cost testing to identify specific variants extending the pandemic. Is this information vital? Well, with COVID-19 not going anywhere, we continue to innovate how to deliver greater insight that can help inform point-of-care insights and public health decisions.
- Cannabinoid Connect Podcast 236: Milan Patel, PathogenDx
Co-Founder and CEO Milan Patel guests on the Cannabinoid Connect Podcast to talk with host Kevin Carrillo about topics ranging from providing disruptive DNA-based pathogen testing technology and solutions to building the future of safe in the cannabis, botanical, food and agricultural industries.
Recent Comments